Your browser doesn't support javascript.
loading
Riluzole and other prognostic factors in ALS: a population-based registry study in Italy.
Mandrioli, Jessica; Malerba, Sara Angela; Beghi, Ettore; Fini, Nicola; Fasano, Antonio; Zucchi, Elisabetta; De Pasqua, Silvia; Guidi, Carlo; Terlizzi, Emilio; Sette, Elisabetta; Ravasio, Alessandro; Casmiro, Mario; Salvi, Fabrizio; Liguori, Rocco; Zinno, Lucia; Handouk, Yasmin; Rizzi, Romana; Borghi, Annamaria; Rinaldi, Rita; Medici, Doriana; Santangelo, Mario; Granieri, Enrico; Mussuto, Vittoria; Aiello, Marina; Ferro, Salvatore; Vinceti, Marco.
  • Mandrioli J; Department of Neuroscience, St. Agostino-Estense Hospital, Azienda Ospedaliero Universitaria di Modena, University of Modena and Reggio Emilia, Via Pietro Giardini n. 1355, 41100, Modena, Italy. j.mandrioli@ausl.mo.it.
  • Malerba SA; Department of Neuroscience, St. Agostino-Estense Hospital, Azienda Ospedaliero Universitaria di Modena, University of Modena and Reggio Emilia, Via Pietro Giardini n. 1355, 41100, Modena, Italy.
  • Beghi E; Department of Neuroscience, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
  • Fini N; Department of Neuroscience, St. Agostino-Estense Hospital, Azienda Ospedaliero Universitaria di Modena, University of Modena and Reggio Emilia, Via Pietro Giardini n. 1355, 41100, Modena, Italy.
  • Fasano A; Department of Neuroscience, St. Agostino-Estense Hospital, Azienda Ospedaliero Universitaria di Modena, University of Modena and Reggio Emilia, Via Pietro Giardini n. 1355, 41100, Modena, Italy.
  • Zucchi E; Department of Neuroscience, St. Agostino-Estense Hospital, Azienda Ospedaliero Universitaria di Modena, University of Modena and Reggio Emilia, Via Pietro Giardini n. 1355, 41100, Modena, Italy.
  • De Pasqua S; Department of Biomedical and Neuromotor Sciences, University of Bologna and IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Guidi C; Department of Neurology, Forlì Hospital, Forlì, Italy.
  • Terlizzi E; Department of Neurology, G. Da Saliceto Hospital, Piacenza, Italy.
  • Sette E; Department of Neurology, St. Anna Hospital, Ferrara, Italy.
  • Ravasio A; Department of Neurology, Infermi Hospital, Rimini, Italy.
  • Casmiro M; Department of Neurology, Faenza and Ravenna Hospital, Ravenna, Italy.
  • Salvi F; Neurology Unit, Bellaria Hospital, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Liguori R; Department of Biomedical and Neuromotor Sciences, University of Bologna and IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Zinno L; Department of Neuroscience, Neurology Unit, University of Parma, Parma, Italy.
  • Handouk Y; Department of Neurology, Bufalini Hospital, Cesena, Italy.
  • Rizzi R; Department of Neurology, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.
  • Borghi A; Neurology Unit, Maggiore Hospital, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Rinaldi R; Department of Neuroscience, St. Orsola-Malpighi University Hospital, Bologna, Italy.
  • Medici D; Department of Neurology, Fidenza Hospital, Parma, Italy.
  • Santangelo M; Department of Neurology, Carpi Hospital, Modena, Italy.
  • Granieri E; Department of Neuroscience, University of Ferrara, Ferrara, Italy.
  • Mussuto V; Department of Neurology, Imola Hospital, Bologna, Italy.
  • Aiello M; Department of Clinical and Experimental Medicine, Respiratory Disease and Lung Function Unit, University of Parma, Parma, Italy.
  • Ferro S; Department of Hospital Services, Emilia Romagna Regional Health Authority, Bologna, Italy.
  • Vinceti M; Environmental, Genetic and Nutritional Epidemiology Research Center (CREAGEN), University of Modena and Reggio Emilia Medical School, Modena, Italy.
J Neurol ; 265(4): 817-827, 2018 Apr.
Article en En | MEDLINE | ID: mdl-29404735

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Resultado del Tratamiento / Fármacos Neuroprotectores / Riluzol / Esclerosis Amiotrófica Lateral Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Resultado del Tratamiento / Fármacos Neuroprotectores / Riluzol / Esclerosis Amiotrófica Lateral Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2018 Tipo del documento: Article